West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 156,600 | 47,100 | 44,800 | 46,100 | 31,300 |
| Receivables | 143,300 | 109,500 | 121,900 | 125,500 | 126,600 |
| Inventories | 107,700 | 97,500 | 94,400 | 87,200 | 86,300 |
| Income taxes - deferred | 5,600 | 5,300 | 3,000 | 2,600 | 2,400 |
| Other current assets | 19,000 | 22,300 | 21,700 | 21,800 | 16,600 |
| TOTAL | $432,200 | $281,700 | $285,800 | $283,200 | $263,200 |
| Non-Current Assets | |||||
| PPE Net | 395,200 | 384,700 | 348,400 | 339,000 | 330,500 |
| Investments And Advances | 29,000 | 29,700 | 28,600 | 28,900 | 27,500 |
| Intangibles | 172,700 | 169,100 | 168,600 | 160,300 | 158,400 |
| Other Non-Current Assets | 77,100 | 53,000 | 63,600 | 72,200 | 71,900 |
| TOTAL | $674,000 | $636,500 | $609,200 | $600,400 | $588,300 |
| Total Assets | $1,106,200 | $918,200 | $895,000 | $883,600 | $851,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 59,500 | 61,200 | 47,500 | 51,500 | 47,400 |
| Accrued Expenses | 30,600 | 55,700 | 34,500 | 27,500 | 59,700 |
| Other current liabilities | 46,300 | 33,100 | 39,100 | 34,700 | N/A |
| TOTAL | $153,300 | $156,900 | $158,500 | $146,600 | $133,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 376,600 | 235,800 | 240,600 | 259,300 | 270,600 |
| aiOther Non-Current Liabilities | 73,300 | 67,500 | 61,800 | 58,100 | 55,800 |
| TOTAL | $493,400 | $346,800 | $333,000 | $348,500 | $356,300 |
| Total Liabilities | $646,700 | $503,700 | $491,500 | $495,100 | $489,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,987 | 66,085 | 65,312 | 64,819 | 64,605 |
| Common Shares | 8,600 | 8,600 | 8,600 | 8,600 | 8,600 |
| Retained earnings | 419,500 | 375,700 | 365,000 | 355,900 | 339,000 |
| Other shareholders' equity | 10,700 | 10,400 | 22,900 | 19,600 | 13,400 |
| TOTAL | $459,500 | $414,500 | $403,500 | $388,500 | $361,800 |
| Total Liabilities And Equity | $1,106,200 | $918,200 | $895,000 | $883,600 | $851,500 |